Hjem › Osteosarkom › Hawaii › Honolulu
Osteosarkom kliniske forsøg i Honolulu, HI
5 studier for Osteosarkom søger deltagere på steder i og omkring Honolulu (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RekruttererFase 1/2
- Kapiolani Medical Center for Women and Children, Honolulu
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RekruttererFase 1/2
- Kapiolani Medical Center for Women and Children, Honolulu
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
RekruttererFase 3
- Kapiolani Medical Center for Women and Children, Honolulu
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RekruttererObservationsstudie
- Kapiolani Medical Center for Women and Children, Honolulu
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Rekrutterer
- Spark M. Matsunaga VA Medical Center, Honolulu
Osteosarkom forsøg i andre byer
- Memphis, TN10 studier
- Atlanta, GA10 studier
- St. Louis, MO10 studier
- Boston, MA9 studier
- Mountain View, CA8 studier
- Chicago, IL7 studier
- Los Angeles, CA7 studier
- Birmingham, AL7 studier
- Houston, TX7 studier
- Tampa, FL6 studier
- Cincinnati, OH6 studier
- Philadelphia, PA6 studier
Andre studier i Honolulu
- Kræft (alle typer)13 studier
- Overvægt13 studier
- Brystkræft12 studier
- Overvægt11 studier
- Ikke-småcellet lungecancer10 studier
- Lungecancer8 studier
- Akut myeloid leukæmi7 studier
- Type 2-diabetes7 studier
- Ægstockræft7 studier
- Bugspytkirtelkræft7 studier
- Neuroblastom6 studier
- Prostatakræft5 studier
Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.